Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

$100M gift launches Sanford Stem Cell Clinical Center

Published: Wednesday, November 06, 2013
Last Updated: Wednesday, November 06, 2013
Bookmark and Share
T. Denny Sanford has committed $100 million to the creation of the Sanford Stem Cell Clinical Center at the University of California, San Diego.

The Sanford Center will accelerate development of drugs and cell therapies inspired by and derived from current human stem cell research; establishing, promoting and disseminating clinical trials and patient therapies that will help more quickly transform promise into reality.

"This gift and the creation of the Sanford Stem Cell Clinical Center will further UC San Diego's leadership in stem cell science and therapeutics, and advance our region's reputation as an international, collaborative hub for stem cell research," said Pradeep K. Khosla, chancellor of UC San Diego. "This center will support the goals and vision of our strategic planning process by translating discoveries into therapies that will improve and save lives."

The Sanford Center will integrate operations at four locations: the UC San Diego Jacobs Medical Center and a nearby proposed clinical space, both scheduled to open in 2016; the UC San Diego Center for Advanced Laboratory Medicine (CALM); and the Sanford Consortium for Regenerative Medicine (SCRM). It will provide essential physical and human resources needed to leverage stem cell research currently being conducted at the Sanford Consortium — an innovative "collaboratory" of San Diego scientists from UC San Diego, the Sanford-Burnham Medical Research Institute, the Salk Institute for Biological Studies, the Scripps Research Institute and the La Jolla Institute for Allergy & Immunology — and other institutions on and around the Torrey Pines mesa, such as the J. Craig Venter Institute.

"Every day, scientists learn more about the regenerative powers of stem cells, which tantalize with their potential to treat, cure, even prevent, myriad afflictions, including cancer, Lou Gehrig's disease and spinal cord injury. I see it in the amazing collaborative advances by researchers and doctors in the Consortium and across the La Jolla mesa," said Sanford. "I believe we're on the cusp of turning years of hard-earned knowledge into actual treatments for real people in need. I want this gift to push that reality faster and farther."

In 2008, Sanford donated $30 million for the development and construction of the Sanford Consortium for Regenerative Medicine facility, which opened in 2011. His gift to create the Sanford Stem Cell Clinical Center is the second largest donation received by UC San Diego in its 53-year history, following only the $110 million gift by Joan and Irwin Jacobs to endow the UC San Diego Jacobs School of Engineering.

Since 2006, the California Institute for Regenerative Medicine (CIRM), the state's stem cell agency, has awarded UC San Diego scientists more than 60 grants totaling almost $138 million, with millions more given to other area institutions. Lawrence Goldstein, PhD, professor in the Departments of Cellular and Molecular Medicine and Neurosciences, director of the UC San Diego Stem Cell Program, and scientific director of the Sanford Consortium for Regenerative Medicine, said funding from CIRM and elsewhere has already helped push some stem cell-based projects into early clinical trials, with more nearing readiness.

"Clinical trials are not the finish line, but they are essential to advancing the science and ultimately creating much-needed drugs and therapies," said Goldstein, who will also serve as director of the new Sanford Center. "We have made profound progress in understanding the basic nature and abilities of stem cells. We know a great deal about how they work and differentiate and, in a number of cases, how to make them become the kinds of cells we think we need. Now we have to put that knowledge to the test in people, for people."

A great deal of the progress in stem cell research has occurred at UC San Diego School of Medicine. For example:

•    Catriona H.M. Jamieson, M.D., Ph.D., associate professor of medicine at UC San Diego School of Medicine and director of the UC San Diego Moores Cancer Center stem cell program, and colleagues are conducting or planning trials for several stem cell-derived treatments of leukemia and other blood diseases that have shown encouraging results in animal models and human clinical trials.

•    Mark H. Tuszynski, M.D., Ph.D, professor in the UC San Diego Department of Neurosciences and director of the UC San Diego Translational Neuroscience Institute, investigates both the slowly evolving neurological damage of Alzheimer's disease and the sudden, catastrophic consequences of traumatic spinal cord injuries. In the latter work, Tuszynski and colleagues recently reported using introduced neural stem cells to regenerate axon growth at the site of severe spinal cord injuries in rats, restoring some movement.

•    Goldstein's lab has created, for the first time, stem cell-derived, in-vitro models of sporadic and hereditary Alzheimer's disease using induced pluripotent stem cells from patients with AD. These functional Alzheimer's neurons in a dish promise to be an unprecedented tool for developing and testing drugs to treat the dreaded neurodegenerative disorder.

The Sanford Stem Cell Clinical Center will advance these and other stem cell projects in crucial ways, said Goldstein, accelerating their movement into clinical trials with patients. The center will deepen the connection with stem cell research partners in San Diego, allowing them to collaborate with one of the country's leading academic medical centers. It will establish the best standards in stem cell testing, safety and efficacy. It will effectively tackle the necessary regulatory requirements. All of these efforts, Goldstein said, are critical to speeding experimental therapies to use by patients.

"This significant philanthropic gift from Mr. Sanford, combined with funding from CIRM and elsewhere, puts UC San Diego in a unique and advantageous position," noted David A. Brenner, M.D., vice chancellor for Health Sciences and dean of the UC San Diego School of Medicine. "We are the only academic medical institution in the region with the scientists, physicians, facilities and clinical delivery system to bring the promise of stem cell therapies to fruition. No place in the world has a better chance of success."

Sanford's donation is the latest in a history of philanthropic largess. In his lifetime, he has given more than $1 billion, primarily to health- and children-related causes, often in his native state of South Dakota. In 2007, for example, he announced a $400 million gift to the Sioux Valley Hospitals and Health System for various health care and research initiatives.

In San Diego, Sanford and his foundation donated $20 million to the Burnham Institute for Medical Research in 2007 and issued a $50 million challenge grant three years later to the renamed Sanford-Burnham Medical Research Institute.

Sanford, 77, resides in Sioux Falls, South Dakota, with vacation homes in Arizona, California and Colorado. His family includes one brother, two sons, and two grandsons.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Monday, February 08, 2016
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Monday, February 08, 2016
Toxic Pollutants Found in Fish Across the World's Oceans
Scripps researchers' analysis shows highly variable pollutant concentrations in fish meat.
Friday, January 29, 2016
Key Enzyme in Pierce’s Disease Grapevine Damage Uncovered
UC Davis plant scientists have identified an enzyme that appears to play a key role in the insect-transmitted bacterial infection of grapevines with Pierce’s disease, which annually costs California’s grape and wine industries more than $100 million.
Wednesday, January 13, 2016
Science Magazine Names CRISPR ‘Breakthrough of the Year’
In its year-end issue, the journal Science chose the CRISPR genome-editing technology invented at UC Berkeley 2015’s Breakthrough of the Year.
Monday, December 21, 2015
Genome Sequencing May Save California's Legendary Sugar Pine
The genome of California’s legendary sugar pine, which naturalist John Muir declared to be “king of the conifers” more than a century ago, has been sequenced by a research team led by UC Davis scientists.
Thursday, December 17, 2015
Cellular “ORACLs” to Aid Drug Discovery
New approach for finding therapeutics is inspired by face-recognition software.
Wednesday, December 16, 2015
New Virus Disovered, Linked To Hepatitis C
Study is first to reveal entire genetic makeup of human pegivirus 2.
Tuesday, December 15, 2015
CRISPR-Cas9 Helps Uncover Genetics of Exotic Organisms
A new study illustrates the ease with which CRISPR-Cas9 can knock out genes in exotic animals to learn how those genes control growth and development.
Friday, December 11, 2015
UC Davis Cracks the Walnut Genome
Scientists at the University of California, Davis, have for the first time sequenced the genome of a commercial walnut variety.
Friday, December 11, 2015
‘Purity’ Of Tumor Samples May Significantly Bias Genomic Analyses
Non-cancerous tumor components influence research findings, clinical classifications, study shows.
Monday, December 07, 2015
New Method for Screening Cancer Cells
Parallel microfiltration could lead to better treatments for a number of diseases, UCLA-led study says.
Thursday, December 03, 2015
Embryonic Switch for Cancer Stem Cell Generation
An international team of scientists report that decreases in a specific group of proteins trigger changes in the cancer microenvironment that accelerate growth and development of therapy-resistant cancer stem cells (CSCs).
Wednesday, December 02, 2015
New Organic Plant Breeding Effort Launched
A new effort to provide California growers with seeds for tomato, bean, pepper and other crop varieties that are specially bred for organic farming has been launched at UC Davis.
Tuesday, December 01, 2015
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Monday, November 30, 2015
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!